Literature DB >> 2820639

Influence of inactivated feline retrovirus on feline alpha interferon and immunoglobulin production.

M Yasuda1, R A Good, N K Day.   

Abstract

The effect of ultraviolet-inactivated feline leukaemia virus (UV-FeLV) on the development of feline immunoglobulin-secreting cells (ISC) was investigated using a reverse haemolytic plaque assay. Low concentrations of UV-FeLV at 2 X 10(-4) to 2.0 micrograms/ml stimulated the production of ISC. By contrast, the same concentration of UV-FeLV suppressed the development of pokeweed mitogen (PWM)-driven ISC. Maximum suppression of ISC occurred at 50 micrograms/ml of UV-FeLV. The generation of an interferon resistant to acid, heat and sodium dodecyl sulphate (SDS) in the media of lymphocyte cultures incubated with PWM was also significantly suppressed in the presence of 0.2 microgram/ml of UV-FeLV. These findings suggest that non-infectious viral particles appear to modify feline immunoglobulin and interferon-secreting systems.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820639      PMCID: PMC1542410     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Inhibition of lymphocyte transformation by disrupted murine oncornavirus.

Authors:  A K Fowler; D R Twardzik; C D Reed; O S Weislow; A Hellman
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

2.  Suppression of gamma interferon production by inactivated feline leukemia virus.

Authors:  R W Engelman; R W Fulton; R A Good; N K Day
Journal:  Science       Date:  1985-03-15       Impact factor: 47.728

3.  Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.

Authors:  L E Mathes; R G Olsen; L C Hebebrand; E A Hoover; J P Schaller; P W Adams; W S Nichols
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

Review 4.  Immunopathology induced by the feline leukemia virus.

Authors:  W D Hardy
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Role of suppressor cells in feline leukemia virus-associated immunosuppression.

Authors:  M Langweiler; G L Cockerell; F deNoronha
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

6.  Inhibition of erythroid colony-forming cells by a Mr 15,000 protein of feline leukemia virus.

Authors:  M L Wellman; G J Kociba; M G Lewis; L E Mathes; R G Olsen
Journal:  Cancer Res       Date:  1984-04       Impact factor: 12.701

7.  Suppression of the humoral antibody response in natural retrovirus infections.

Authors:  Z Trainin; D Wernicke; H Ungar-Waron; M Essex
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  Effects of retrovirus protein on the feline one-way mixed leukocyte reaction.

Authors:  M I Stiff; R G Olsen
Journal:  J Gen Virol       Date:  1983-04       Impact factor: 3.891

9.  Remission of leukemia and loss of feline leukemia virus in cats injected with Staphylococcus protein A: association with increased circulating interferon and complement-dependent cytotoxic antibody.

Authors:  W T Liu; R A Good; L Q Trang; R W Engelman; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

10.  Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice.

Authors:  D E Mosier; R A Yetter; H C Morse
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

View more
  2 in total

1.  Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections.

Authors:  S Haraguchi; R A Good; M James-Yarish; G J Cianciolo; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

2.  Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein.

Authors:  S Haraguchi; R A Good; M James-Yarish; G J Cianciolo; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.